Johnson and Johnson (JNJ) |
| 265.58 -0.77 (-0.29%) 09-11 16:00 |
| Open: | 268.225 |
| High: | 270.385 |
| Low: | 265.25 |
| Volume: | 4,389,477 |
| Market Cap: | 640,021(M) |
| PE Ratio: | 24.75 |
| Exchange: | New York Stock Exchange |
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 281.07 |
| Resistance 1: | 270.68 |
| Pivot price: | 270.11 |
| Support 1: | 253.87 |
| Support 2: | 211.22 |
| 52w High: | 281.07 |
| 52w Low: | 173.33 |
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Financials
| EPS | 8.610 |
| Book Value | 35.280 |
| PEG Ratio | 4.44 |
| Gross Profit | 27.689 |
| Profit Margin (%) | 21.48 |
| Operating Margin (%) | 29.19 |
| Return on Assets (ttm) | 8.6 |
| Return on Equity (ttm) | 25.7 |
Company news
Sat, 12 Sep 2026
Johnson & Johnson (JNJ) Weighs DePuy Synthes Exit In MedTech Portfolio Reset - simplywall.st
Sat, 12 Sep 2026
Is Johnson & Johnson (NYSE:JNJ) Making A Bigger MedTech Shift? - Kalkine Media
Sat, 12 Sep 2026
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Pick for Income Investors - ChartMill
Fri, 11 Sep 2026
Apollo in talks to acquire J&J’s orthopedics unit - Bloomberg (JNJ:NYSE) - Seeking Alpha
Fri, 11 Sep 2026
JNJ Stock Edges Up After-Hours On Apollo’s $20B Orthopedics Talks - Yahoo Finance
Fri, 11 Sep 2026
J&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports - Reuters
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
